chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK FOUR UNREFRIGERATED DOSES; A spontaneous case report was received from a consumer on 25-Feb-2019 for two consumers.  Based on the information obtained from the consumer, two individual case safety reports PVX201902-000150 (PVX2019-502; wife) and PVX201902-000151 (PVX2019-503, husband) were created and cross-linked in the database.  This case report describes a 59-year-old female consumer who "took four unrefrigerated doses". The consumer was receiving oral Vivotif (one dose every other day; lot no: 3003241) for typhoid fever prophylaxis.  It was reported that the consumer did not refrigerate Vivotif for 24 hours and took all the doses. The first dose was taken on 17-Feb-2019 and the last was on 23-Feb-2019.  The action taken with Vivotif with respect to event "took four unrefrigerated doses" was not applicable.  The clinical outcome of the event "took four unrefrigerated doses" was unknown.  Company's Comment: The causality of the event "took four unrefrigerated doses" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took four unrefrigerated doses" was considered as not applicable. US-PaxVax Berna GmbH-PVX201902-000151:
Sex: M
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK FOUR UNREFRIGERATED DOSES; A spontaneous case report was received from a caregiver on 25-Feb-2019 for two consumers.  Based on the information obtained from the caregiver, two individual case safety reports PVX201902-000150 (PVX2019-502; wife) and PVX201902-000151 (PVX2019-503, husband) were created and cross-linked in the database.  This case report describes a male consumer who "took four unrefrigerated doses". The consumer was receiving oral Vivotif (one dose every other day; lot no: 3003240) for typhoid fever prophylaxis.  It was reported that the consumer did not refrigerate Vivotif for two weeks and later took all the doses. The first dose was taken on 17-Feb-2019 and the last was on 23-Feb-2019.  The action taken with Vivotif with respect to event "took four unrefrigerated doses" was not applicable.  The clinical outcome of the event "took four unrefrigerated doses" was unknown.  Company's Comment: The causality of the event "took four unrefrigerated doses" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took four unrefrigerated doses" was considered as not applicable. US-PaxVax Berna GmbH-PVX201902-000150:
Sex: F
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK AN UNREFRIGERATED DOSE; A spontaneous case report was received from a caregiver on 25-Feb-2019 for two consumers.  Based on the information obtained from the caregiver, two individual case safety reports PVX201902-000152 (PVX2019-513; female child) and PVX201902-000153 (PVX2019-514, male child) were created and cross-linked in the database.  This case report describes a 16-year-old female consumer who "took an unrefrigerated dose". The consumer was receiving Vivotif for an unknown indication.  It was reported that the consumer picked Vivotif on 20-Feb-2019 and left it outside of the refrigerator since then. She then took her unrefrigerated first dose on 25-Feb-2019.  The action taken with Vivotif with respect to event "took an unrefrigerated dose" was not applicable.  The clinical outcome of the event "took an unrefrigerated dose" was unknown.  Company's Comment: The causality of the event "took unrefrigerated dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took unrefrigerated dose" was considered as not applicable. US-PaxVax Berna GmbH-PVX201902-000153:
Sex: M
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK AN UNREFRIGERATED DOSE; A spontaneous case report was received from a caregiver on 25-Feb-2019 for two consumers.  Based on the information obtained from the caregiver, two individual case safety reports PVX201902-000152 (PVX2019-513; female child) and PVX201902-000153 (PVX2019-514, male child) were created and cross-linked in the database.  This case report describes a 13-year-old male consumer who "took an unrefrigerated dose". The consumer was receiving Vivotif for an unknown indication.  It was reported that the consumer picked Vivotif on 20-Feb-2019 and left it outside of the refrigerator since then. She took her unrefrigerated first dose on 25-Feb-2019.  The action taken with Vivotif with respect to event "took an unrefrigerated dose" was not applicable.  The clinical outcome of the event "took an unrefrigerated dose" was unknown.  Company's Comment: The causality of the event "took an unrefrigerated dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took an unrefrigerated dose" was considered as not applicable. US-PaxVax Berna GmbH-PVX201902-000152:
Sex: F
Vaccine: TYP
Symptoms: Incomplete course of vaccination
Clinical narrative: TOOK ONLY TWO DOSES; This spontaneous case report was received from a pharmacist (PVX2019-521) on 26-Feb-2019. The report described a female consumer who "took only two doses". The consumer was receiving Vivotif for typhoid prophylaxis.  It was reported that the consumer took the two doses of Vivotif and then forgot to take the other two doses for about two weeks.   The action taken with Vivotif with respect to the event "took only two doses" was not applicable.  The clinical outcome of the event "took only two doses" was unknown.  Company's Comment: The causality of the event "took only two doses" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took only two doses" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK TWO DOSES IN A ROW; This spontaneous case report was received from a pharmacist (PVX2019-528) on 27-Feb-2019. The report described a female consumer who "took two doses in a row". The consumer was receiving Vivotif for typhoid prophylaxis.  It was reported that the consumer took two doses of Vivotif in a row. The doses were taken on 26-Feb-2019 and 27-Feb-2019, respectively.  The action taken with Vivotif with respect to the event "took two doses in a row" was not applicable.  The clinical outcome of the event "took two doses in a row" was unknown.  Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.
Sex: U
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK ALL FOUR DOSES AT THE SAME TIME; This spontaneous case report was received from a pharmacist (PVX2019-533) on 27-Feb-2019. The report describes an adult consumer who "took all four doses at the same time". The consumer was receiving Vivotif for an unknown indication.  It was reported that the consumer took all the four doses of Vivotif at the same time.  The action taken with Vivotif with respect to the event "took all four doses at the same time" was not applicable.  The clinical outcome of the event "took all four doses at the same time" was unknown.  Company's Comment: The causality of the event "took all four doses at the same time" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took all four doses at the same time" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK VIVOTIF TOO CLOSE TO TRAVEL; This spontaneous case report was received from a pharmacist (PVX2019-540) on 28-Feb-2019. The report describes a female consumer who "took Vivotif too close to travel". The consumer was receiving Vivotif (lot number: 3003248 and expiry date: Nov 2019) for an unknown indication.  It was reported that the consumer started Vivotif on 25-Feb-2019 and she will be leaving on 01-Mar-2019.  The action taken with Vivotif with respect to the event "took Vivotif too close to travel" was not applicable.  The clinical outcome of the event "took Vivotif too close to travel" was unknown.  Company's Comment: The causality of the event "took Vivotif too close to travel" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took Vivotif too close to travel" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK TWO DOSES IN A ROW; This spontaneous case report was received from a nurse (PVX2019-550) on 28-Feb-2019. The report describes a female consumer who "took two doses in a row". The consumer was receiving Vivotif for an unknown indication.  It was reported that the consumer took the first dose of Vivotif on 27-Feb-2019 and today she took another dose.  The action taken with Vivotif with respect to the event "took two doses in a row" was not applicable.  The clinical outcome of the event "took two doses in a row" was unknown.  Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK ALL FOUR DOSES AT ONCE; A spontaneous case report was received from a nurse on 28-Feb-2019 for two consumers.  Based on the information obtained from the nurse, two individual case safety reports PVX201903-000162 (PVX2019-551; younger female) and PVX201903-000163 (PVX2019-552, elder female) were created and cross-linked in the database.  This case report describes a 44-year-female consumer who "took all four doses at once". The consumer was receiving Vivotif for an unknown indication.  It was reported that the consumer took all the four doses of Vivotif on 08-Feb-2019.  The action taken with Vivotif with respect to event "took all four doses at once" was not applicable.  The clinical outcome of the event "took all four doses at once" was unknown.  Company's Comment: The causality of the event "took all four doses at once" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took all four doses at once" was considered as not applicable. US-PaxVax Berna GmbH-PVX201903-000163:
Sex: F
Vaccine: TYP
Symptoms: Incomplete course of vaccination
Clinical narrative: TOOK ONLY THREE DOSES; A spontaneous case report was received from a nurse on 28-Feb-2019 for two consumers.  Based on the information obtained from the nurse, two individual case safety reports PVX201903-000162 (PVX2019-551; younger female) and PVX201903-000163 (PVX2019-552, elder female) were created and cross-linked in the database.  This case report describes a female consumer who "took only three doses". The consumer was receiving Vivotif for an unknown indication.  It was reported that the consumer took only three doses of Vivotif and forgot to take the fourth dose.  The action taken with Vivotif with respect to event "took only three doses" was not applicable.  The clinical outcome of the event "took only three doses" was unknown.  Company's Comment: The causality of the event "took only three doses" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took only three doses" was considered as not applicable. US-PaxVax Berna GmbH-PVX201903-000162:
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: SKIPPED TWO DAYS BETWEEN THE SECOND AND THIRD DOSE; This spontaneous case report was received from a caregiver (PVX2019-555) on 01-Mar-2019. The report describes a female consumer who "skipped two days between the second and third dose". The consumer was receiving oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  It was reported that the consumer skipped two days between the second and third dose". The doses were taken on 22-Feb-2019, 24-Feb-2019, 27-Feb-2019, and 01-Mar-2019 respectively.  The action taken with Vivotif with respect to the event "skipped two days between the second and third dose" was not applicable.  The clinical outcome of the event "skipped two days between the second and third dose" was unknown.  Company's Comment: The causality of the event "skipped two days between the second and third dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "skipped two days between the second and third dose" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK FOUR UNREFRIGERATED DOSES; This spontaneous case report was received from a pharmacist (PVX2019-548) on 28-Feb-2019. The report described a 62-year-old female consumer who "took four unrefrigerated doses". The consumer was receiving oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  It was reported that the consumer took four doses of Vivotif that were stored unrefrigerated.  The action taken with Vivotif with respect to the event "took four unrefrigerated doses" was not applicable.  The clinical outcome of the event "took four unrefrigerated doses" was unknown.  Company's Comment: The causality of the event "took four unrefrigerated doses" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took four unrefrigerated doses" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK AN UNREFRIGERATED DOSE; This spontaneous case report was received from a consumer (PVX2019-565) on 04-Mar-2019. The report described a female consumer who "took an unrefrigerated dose". The consumer was receiving oral Vivotif (one dose every other day; lot no: 3003239) for typhoid fever prophylaxis.  It was reported that the consumer took the first dose of Vivotif that was unrefrigerated for around 17 to 18 hours at 68 degree Fahrenheit.  The action taken with Vivotif with respect to the event "took an unrefrigerated dose" was not applicable.  The clinical outcome of the event "took an unrefrigerated dose" was unknown.  Company's Comment: The causality of the event "took an unrefrigerated dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took an unrefrigerated dose" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Incomplete course of vaccination
Clinical narrative: MISSED THE FINAL DOSE; This spontaneous case report was received from a pharmacist on 07-Mar-2019. It described a male consumer who "missed the final dose". The consumer was receiving Vivotif for travel.  It was reported that the consumer missed his final dose of Vivotif.  The action taken with Vivotif with respect to the event "missed the final dose" was not applicable.  The clinical outcome of the event "missed the final dose" was unknown.  Company's Comment: The causality of the event "missed the final dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed the final dose" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Contraindication to vaccination
Clinical narrative: TOOK VIVOTIF WITH MINOCYCLINE; This spontaneous case report was received from a pharmacist (PVX2019-599) on 08-Mar-2019. It described a 17-year-old adolescent male consumer who "took Vivotif with minocycline". The consumer was receiving oral Vivotif (one capsule every other day) for typhoid prophylaxis and oral minocycline for prevention of acne vulgaris.  It was reported that the consumer took first two doses of Vivotif while taking minocycline. The Vivotif doses were taken on 04-Mar-2019 and 06-Mar-2019, respectively.  The action taken with Vivotif and minocycline with respect to the event "took Vivotif with minocycline" was not applicable.  The clinical outcome of the event "took Vivotif with minocycline" was unknown.  Company's Comment: The causality of the event "took Vivotif with minocycline" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took Vivotif with minocycline" was considered as not applicable.
Sex: U
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK A DOSE A DAY EARLY; This spontaneous case report was received from a nurse (PVX2019-605) on 08-Mar-2019. It described a 13-year-old adolescent consumer who "took a dose a day early". The consumer was receiving Vivotif for an unknown indication.  It was reported that the consumer took the fourth dose of Vivotif on day 6. The doses were taken on 02-Mar-2019, 04-Mar-2019, 06-Mar-2019, and 07-Mar-2019, respectively.  The action taken with Vivotif with respect to the event "took a dose a day early" was not applicable.  The clinical outcome of the event "took a dose a day early" was unknown.  Company's Comment: The causality of the event "took a dose a day early" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took a dose a day early" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK THREE UNREFRIGERATED DOSES; This spontaneous case report was received from a pharmacist (PVX2019-610) on 08-Mar-2019. It described a 71-year-old elderly female consumer who "took three unrefrigerated doses". The consumer was receiving Vivotif for an unknown indication.  It was reported that the consumer took the first dose of Vivotif correctly and then left the remaining three doses out of the fridge and took them all. She would be travelling on 14-Mar-2019.  The action taken with Vivotif with respect to the event "took three unrefrigerated doses" was not applicable.  The clinical outcome of the event "took three unrefrigerated doses" was unknown.  Company's Comment: The causality of the event "took three unrefrigerated doses" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took three unrefrigerated doses" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK VIVOTIF ON DAY 1, 3, 5, AND 6; This spontaneous case report was received from a pharmacist (PVX2019-612) on 11-Mar-2019. It described a 68-year-old elderly male consumer who "took Vivotif on day 1, 3, 5, and 6". The consumer was receiving Vivotif for an unknown indication.  It was reported that the consumer took Vivotif doses in an inappropriate way. The doses were taken on day 1, 3, 5, and 6.  The action taken with Vivotif with respect to the event "took Vivotif on day 1, 3, 5, and 6" was not applicable.  The clinical outcome of the event "took Vivotif on day 1, 3, 5, and 6" was unknown.  Company's Comment: The causality of the event "took Vivotif on day 1, 3, 5, and 6" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took Vivotif on day 1, 3, 5, and 6" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Product administration error
Clinical narrative: TOOK VIVOTIF WITH HOT WATER; This spontaneous case report was received from a pharmacist (PVX2019-624) on 08-Mar-2019. It described a female consumer who "took Vivotif with hot water". The consumer was receiving oral Vivotif for an unknown indication.  It was reported that the consumer took the first dose of Vivotif with hot water out of the tap.  The action taken with Vivotif with respect to the event "took Vivotif with hot water" was not applicable.  The clinical outcome of the event "took Vivotif with hot water" was unknown.  Company's Comment: The causality of the event "took Vivotif with hot water" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took Vivotif with hot water" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: MISSED THE THIRD DOSE; This spontaneous case (PVX2019-1491) was received from a consumer on 10-Jun-2019. It describes a 46-year-old adult female consumer who "missed the third dose". The consumer was receiving Vivotif for an unknown indication.  Case report: The consumer took the first two doses of Vivotif on 05-Jun-2019 and 07-Jun-2019, respectively. She missed her third dose which was due on 09-Jun-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "missed the third dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed the third dose" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: DID NOT KEEP VIVOTIF IN REFRIGERATOR BEFORE COMPLETING THE DOSES; This spontaneous case (PVX2019-1497) was received from a pharmacist on 10-Jun-2019. It describes a 17-year-old adolescent male consumer who "did not keep Vivotif in refrigerator before completing the doses". The consumer was receiving Vivotif for an unknown indication.  Case report: The consumer did not keep Vivotif doses in the refrigerator and took all the doses.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "did not keep Vivotif in refrigerator before completing the doses" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "did not keep Vivotif in refrigerator before completing the doses" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Unevaluable event
Clinical narrative: TRAVELING TO AN ENDEMIC AREA ONE DAY AFTER COMPLETING VIVOTIF; This spontaneous case (PVX2019-1499) was received from a pharmacist on 10-Jun-2019. It describes a 74-year-old male consumer who was "traveling to an endemic area one day after completing Vivotif". The consumer was receiving oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer last dose was due on Sunday. He had a planned trip to an endemic area on Monday.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "traveling to an endemic area one day after completing Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "traveling to an endemic area one day after completing Vivotif" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Expired product administered
Clinical narrative: TOOK ALL DOSES OF EXPIRED VIVOTIF; This spontaneous case (PVX2019-1505) was received from a pharmacist on 11-Jun-2019. It describes a female consumer who "took all doses of expired Vivotif". The consumer was receiving Vivotif (expiry date: Apr 2019) for an unknown indication.  Case report: The consumer took all the expired doses of Vivotif. The doses were expired on Apr 2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took all doses of expired Vivotif" was considered as not applicable. ; Sender's Comments: Company's Comment: The causality of the event "took all doses of expired Vivotif" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK TWO DOSES IN A ROW; This spontaneous case (PVX2019-1507) was received from a nurse on 11-Jun-2019. It describes an adult female consumer who "took two doses in a row". The consumer was receiving oral Vivotif (one capsule every other day) for typhoid prophylaxis.  Case report: The consumer took two doses of Vivotif in a row. The doses were taken on 06-Jun-2019 and 07-Jun-2019, respectively.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: MISSED TO TAKE THE LAST DOSE ON TIME; This spontaneous case report (PVX2019-1628) was received from pharmacist on 24-Jun-2019. It describes a male consumer who "missed to take the last dose on time", while being on oral Vivotif (one capsule every other day) for typhoid fever prophylaxis.  Case report: The consumer took three doses of Vivotif every other day but forgot to take the fourth dose which was due on 23-Jun-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "missed to take the last dose on time" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed to take the last dose on time" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK THIRD DOSE ON DAY 6; This spontaneous case (PVX2019-1636) was received from a pharmacist on 24-Jun-2019. It describes a 13-year-old adolescent male consumer who "took third dose on day 6" while being on Vivotif for an unknown indication.  Case report: The consumer took the third dose of Vivotif on day 6. The doses were taken on 18-Jun-2019, 20-Jun-2019, and 23-Jun-2019, respectively.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took third dose on day 6" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took third dose on day 6" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK UNREFRIGERATED VIVOTIF; This spontaneous case report (PVX2019-1658) was received from a pharmacist on 26-Jun-2019. It describes a female consumer who "took unrefrigerated Vivotif". She was receiving Vivotif for an unknown indication.  Case report: The consumer took three doses of Vivotif that was unrefrigerated for 6 days.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took unrefrigerated Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took unrefrigerated Vivotif" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK VIVOTIF ON DAY 1, 4, AND 6; This spontaneous case report (PVX2019-1659) was received from a pharmacist on 26-Jun-2019. It describes an adult female consumer who "took Vivotif on day 1, 4, and 6". She was receiving Vivotif for an unknown indication.  Case report: The consumer took Vivotif doses on day 1, 4, and 6. The first and the third dose were taken on 21-Jun-2019 and 26-Jun-2019, respectively.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took Vivotif on day 1, 4, and 6" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took Vivotif on day 1, 4, and 6" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK ONE DOSE OF UNREFRIGERATED VIVOTIF; This spontaneous case report (PVX2019-1686) was received from a pharmacist on 28-Jun-2019. It describes a male consumer who "took one dose of unrefrigerated Vivotif" (Product storage error). He was receiving oral Vivotif for typhoid fever prophylaxis.  Case report: The consumer took an unrefrigerated dose of Vivotif. He left Vivotif unrefrigerated at room temperature for 48 hours before taking it.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took one dose of unrefrigerated Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took one dose of unrefrigerated Vivotif" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK ONE DOSE OF UNREFRIGERATED VIVOTIF; This spontaneous case report (PVX2019-1714) was received from pharmacist on 01-Jul-2019. It describes a female consumer who "took one dose of unrefrigerated Vivotif", while being on oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer took the first two doses of Vivotif that was refrigerated. The second dose was taken on 27-Jun-2019. Then, she left Vivotif unrefrigerated for 48 hours and took the third dose on 29-Jun-2019.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took one dose of unrefrigerated Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took one dose of unrefrigerated Vivotif" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Incomplete course of vaccination
Clinical narrative: TOOK ONLY ONE DOSE OF VIVOTIF IN APRIL; This spontaneous case report (PVX2019-1720) was received from a consumer on 01-Jul-2019. It describes a female consumer who "took only one dose of Vivotif in April", while being on Vivotif for an unknown indication.  Case report: The consumer took only one dose of Vivotif in April. Then, she went out of town. Thus, did not take another dose.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took only one dose of Vivotif in April" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took only one dose of Vivotif in April" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: MISSED DOSE ON SUNDAY; This spontaneous case report (PVX2019-1722) was received from a pharmacist on 01-Jul-2019. It describes a 16-year-old adolescent female consumer who "missed dose on Sunday", while being on Vivotif for an unknown indication.  Case report: The consumer took only two doses of Vivotif on 26-Jun-2019 and 28-Jun-2019, respectively. Then, she went out of the town and missed her dose. She would not return until 04Jul-2019.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "missed dose on Sunday" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed dose on Sunday" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: DID NOT COMPLETE HER IMMUNIZATION ONE WEEK PRIOR TO TRAVEL; A spontaneous case report was received from a consumer on 02-Jun-2019 for two consumers.  Based on the information obtained from the consumer, 2 individual case safety reports PVX201907-000560 (PVX2019-1729; female consumer) and PVX201907-000561 (PVX2019-1729) were created and cross-linked in the database.  This case describes a female consumer who "did not complete her immunization one week prior to travel". She was receiving Vivotif for foreign travel.   Case report: The consumer started taking Vivotif on 26-Jun-2019 and took her last dose on 02-Jul-2019. Meanwhile, on 29-Jun-2019 she travelled.   Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "did not complete her immunization one week prior to travel" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "did not complete her immunization one week prior to travel" was considered as not applicable. US-PaxVax Berna GmbH-PVX201907-000561:
Sex: M
Vaccine: TYP
Symptoms: Contraindication to vaccination, Inappropriate schedule of product administration
Clinical narrative: DID NOT COMPLETE HER IMMUNIZATION ONE WEEK PRIOR TO TRAVEL/ TOOK THIRD DOSE ON DAY 6; TOOK VIVOTIF WITH ANTIBIOTIC; A spontaneous case report was received from a consumer on 02-Jun-2019 for two consumers.  Based on the information obtained from the consumer, 2 individual case safety reports PVX201907-000560 (PVX2019-1729; female) and PVX201907-000561 (PVX2019-1729, male) were created and cross-linked in the database.  This case describes a 19-year-old male consumer who "did not complete her immunization one week prior to travel/ took third dose on day 6" (PT: Inappropriate schedule of vaccine administered) and "took Vivotif with antibiotic" (PT: Labelled drug-drug interaction medication error). He was receiving Vivotif for a foreign travel and amoxicillin (for 7days) for wisdom teeth removal.   Case report: The consumer took the first and the second dose of Vivotif on 26-Jun-2019 and 28-Jun-2019, respectively. He lost the remaining two doses. He obtained a new pack and took the next dose on 01-Jul-2019 along with a dose of amoxicillin in the evening. He took another dose of amoxicillin on 02-Jul-2019 in the morning for his wisdom teeth removal. The procedure was planned before Vivotif was started. He had a planned travel on 08-Jul-2019.  Action taken with Vivotif and amoxicillin with respect to the events was not applicable.  The clinical outcome of the events was unknown.  Company's Comment: The causality of the event "did not complete her immunization one week prior to travel/ took third dose on day 6" and "took Vivotif with antibiotic" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "did not complete her immunization one week prior to travel/ took third dose on day 6" and "took Vivotif with antibiotic" was considered as not applicable. US-PaxVax Berna GmbH-PVX201907-000560:
Sex: F
Vaccine: TYP
Symptoms: Incomplete course of vaccination
Clinical narrative: DID NOT TAKE FOURTH DOSE; This spontaneous case report (PVX2019-1737) was received from a healthcare professional on 02-Jul-2019. It describes a female consumer who "did not take fourth dose" (PT: Incomplete course of vaccination), while being on Vivotif for an unknown indication.  Case report: The consumer took three doses of Vivotif but did not take the fourth dose. The last dose had been taken a week ago.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "did not take fourth dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "did not take fourth dose" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK VIVOTIF THAT WAS ABOVE RECOMMENDED TEMPERATURE FOR UNKNOWN DURATION; This spontaneous case report (PVX2019-1721) was received from a pharmacist on 01-Jul-2019. It describes a 16-year-old adolescent female consumer who "took Vivotif that was above recommended temperature for an unknown duration" (PT: Product storage error), while being on Vivotif for an unknown indication.  Case report: The consumer took doses of Vivotif that was stored above recommended temperature for an unknown duration.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took Vivotif that was above recommended temperature for an unknown duration" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took Vivotif that was above recommended temperature for an unknown duration" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration, Product storage error
Clinical narrative: TOOK THE THIRD DOSE ON DAY 7/ DID NOT COMPLETE VIVOTIF DOSES PRIOR TO TRAVEL; TOOK UNREFRIGERATED DOSES OF VIVOTIF; This spontaneous case report (PVX2019-1751) was received from a consumer on 06-Jul-2019. It describes a female consumer who "took the third dose on day 7/ did not complete Vivotif doses prior to travel" (PT: Inappropriate schedule of product administration) and "took unrefrigerated doses of Vivotif" (PT: Product storage error). The consumer was receiving Vivotif (lot number: 3003242) for a trip.  Case report: The consumer did not take Vivotif doses according to the schedule. The doses were taken on 27-Jun-2019, 28-Jun-2019, 03-Jul-2019, and 05-Jul-2019 respectively. She had a power cut for 24 hours before starting Vivotif. She stated that she was not sure about what the temperature reached during the storage of doses. She had a planned trip on next Sunday.  Action taken with Vivotif was not applicable.  The clinical outcome of the events was unknown.  Company's Comment: The causality of the event "took the third dose on day 7/ did not complete Vivotif doses prior to travel" and "took unrefrigerated doses of Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took the third dose on day 7/ did not complete Vivotif doses prior to travel" and "took unrefrigerated doses of Vivotif" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK SECOND DOSE A DAY LATE; This spontaneous case report (PVX2019-1762) was received from a pharmacist on 08-Jul-2019. It describes a female consumer who "took second dose a day late" (PT: Inappropriate schedule of product administration), while being on oral Vivotif (one dose every other day) (lot number: 3003279) for typhoid fever prophylaxis.  Case report: The consumer took the first dose of Vivotif on 03-Jul-2019. Then, she took the second dose on 06-Jul-2019 instead of 05-Jul-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took second dose a day late" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took second dose a day late" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK A DOSE OF VIVOTIF THAT WAS LEFT IN THE CAR FOR ABOUT AN HOUR; This spontaneous case report (PVX2019-1772) was received from a pharmacist on 10-Jul-2019. It describes a male consumer who "took a dose of Vivotif that was left in the car for about an hour", while being on Vivotif for an unknown indication.  Case report: The consumer took the first dose of Vivotif on 09-Jul-2019, which was unrefrigerated in a car over 77-degree Fahrenheit for about an hour.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took a dose of Vivotif that was left in the car for about an hour" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took a dose of Vivotif that was left in the car for about an hour" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Incomplete course of vaccination
Clinical narrative: TOOK ONLY TWO DOSES OF VIVOTIF; This spontaneous case report (PVX2019-1778) was received from a nurse on 10-Jul-2019. It describes a female consumer who "took only two doses of Vivotif", while being on Vivotif for an unknown indication.  Case report: The consumer took only two doses of Vivotif two weeks ago, and then did not take the rest doses.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took only two doses of Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took only two doses of Vivotif" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: MISSED TO TAKE HIS THIRD DOSE OF VIVOTIF ACCORDING TO SCHEDULE; This spontaneous case report (PVX2019-1784) was received from a nurse on 11-Jul-2019. It describes an 18-year-old male consumer who "missed to take his third dose of Vivotif according to schedule", while being on oral Vivotif (lot number: 3003253) for typhoid fever prophylaxis.  Case report: The consumer was supposed to take his third dose of Vivotif 10-Jul-2019 but forgot to take it. He missed the dose as he left on a local road trip.   Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "missed to take his third dose of Vivotif according to schedule" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed to take his third dose of Vivotif according to schedule" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Product administration error
Clinical narrative: TOOK VIVOTIF 1 HOUR AFTER EATING FOUR PIECES OF PIZZA; This spontaneous case report (PVX2019-1787) report was received from a healthcare professional on 11-Jul-2019. It describes a 26-year-old adult male consumer who "took Vivotif 1 hour after eating four pieces of pizza", (PT: Product administration error) while being on oral Vivotif (one dose every other day) for typhoid prophylaxis.  Case report: The consumer took the first dose of Vivotif 1 hour after eating four pieces of pizza. The first dose was taken on 09-Jul-2019 and the second dose was taken on 11-Jul-2019 (without food).  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took Vivotif 1 hour after eating four pieces of pizza" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took Vivotif 1 hour after eating four pieces of pizza" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Incomplete course of vaccination, Product storage error
Clinical narrative: MISSED TO TAKE SECOND DOSE ON DAY 3; This spontaneous case report (PVX2019-1789) was received from a pharmacist on 11-Jul-2019. It describes a female consumer who "missed to take second dose on day 3" (PT: Product dose omission), while being on oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer took only first dose of Vivotif on Monday and did not take the second dose on day 3. She did not take other doses as she forgot to refrigerate remaining Vivotif doses.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "missed to take second dose on day 3" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed to take second dose on day 3" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Product storage error
Clinical narrative: TOOK UNREFRIGERATED COURSE OF VIVOTIF; This spontaneous case report (PVX2019-1797) was received from a pharmacist on 12-Jul-2019. It describes a female consumer who "took unrefrigerated course of Vivotif" (PT: Product storage error), while being on Vivotif for an unknown indication.  Case report: The consumer left Vivotif out of the refrigerator for a week at room temperature. She took all the unrefrigerated doses in April   Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took unrefrigerated course of Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took unrefrigerated course of Vivotif" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Contraindication to vaccination
Clinical narrative: TOOK ANTIBIOTICS WITHIN THREE DAYS AFTER VIVOTIF; This spontaneous case report (PVX2019-1798) was received from a pharmacist on 12-Jul-2019. It describes a female consumer who "took antibiotics within three days after Vivotif" (PT: Labelled drug-drug interaction medication error). The consumer was receiving oral Vivotif (one dose every other day) for typhoid fever prophylaxis and clindamycin (600 mg) for wisdom teeth extraction.  Case report: The consumer took the first dose of Vivotf either on 11-Jul-2019 or 10-Jul-2019. On 11-Jul-2019 and 12-Jul-2019, she took clindamycin for wisdom teeth extraction, which was planned prior to staring Vivotif.  Action taken with Vivotif and Clindamycin was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took antibiotics within three days after Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took antibiotics within three days after Vivotif" was considered as not applicable.
Sex: F
Vaccine: TYP
Symptoms: Product administration error
Clinical narrative: TOOK TWO DOSES OF VIVOTIF WITH FOOD; This spontaneous case report (PVX2019-1811) was received from a pharmacist on 15-Jul-2019. It describes a female consumer who "took two doses of Vivotif with food" (PT: Product administration error). The consumer was receiving oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer took first two doses of Vivotif with food, last week.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took two doses of Vivotif with food" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses of Vivotif with food" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: TOOK LAST DOSE OF VIVOTIF TWO DAYS LATE; This spontaneous case report (PVX2019-1813) was received from a caregiver on 15-Jul-2019. It describes a male consumer who "took last dose of Vivotif two days late" (PT: Inappropriate schedule of product administration). The consumer was receiving Vivotif for an unknown indication.  Case report: The consumer took the last dose of Vivotif two days late. The doses were taken on 25-Jun-2019, 27-Jun-2019, 29-Jun-2019, and 03-Jul-2019, respectively.  Action taken with Vivotif was not applicable.  The clinical outcome of the events was unknown.  Company's Comment: The causality of the event "took last dose of Vivotif two days late" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took last dose of Vivotif two days late" was considered as not applicable.
Sex: M
Vaccine: TYP
Symptoms: Incomplete course of vaccination
Clinical narrative: TOOK ONLY ONE DOSE OF VIVOTIF; This spontaneous case report (PVX2019-2065) was received from a healthcare professional on 09-Aug-2019. It described a male consumer who "took only one dose of Vivotif" (PT: Incomplete course of vaccination), while being on oral Vivotif for typhoid fever prophylaxis.  Case report: The consumer took only one dose of Vivotif on 25-Jun-2019 and threw the remaining doses.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took only one dose of Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took only one dose of Vivotif" was considered as not applicable.